Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL8982051 | 0.95 | POLB (0.33) | POLBCYP3A4TSHRPIK3CAALDH1A1 | |
| SCHEMBL10961520 | 0.95 | POLB (0.33) | POLBCYP3A4TSHRPIK3CAALDH1A1 | |
| SCHEMBL392463 | 0.90 | POLB (0.35) | POLBCYP3A4TSHRPIK3CAALDH1A1 | |
| SCHEMBL7140390 | 0.90 | POLB (0.35) | POLBCYP3A4TSHRPIK3CAALDH1A1 | |
| SCHEMBL25011939 | 0.86 | POLB (0.33) | POLBCYP3A4TSHRPIK3CAALDH1A1 | |
| SCHEMBL682204 | 0.86 | POLB (0.33) | POLBCYP3A4TSHRPIK3CAALDH1A1 | |
| SCHEMBL15926028 | 0.84 | POLB (0.37) | POLBCYP3A4TSHRPIK3CAALDH1A1 | |
| SCHEMBL263364 | 0.84 | POLB (0.37) | POLBCYP3A4TSHRPIK3CAALDH1A1 | |
| Hydrochloric Acid SCHEMBL2142090 | 0.80 | POLB (0.35) | POLBCYP3A4TSHRPIK3CAALDH1A1 | |
| SCHEMBL14308323 | 0.80 | POLB (0.35) | POLBCYP3A4TSHRPIK3CAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 948 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260117276-A1 | Frozen Biofluids Mitochondrial Bioenergetics Function Assessment Method for Traumatic Brain Injury and Polytrauma | The Government of the United States, as represented by the Director of the Defense Health Agency (US) | 2026-04-30 | — | — | US | claimed |
| EP-3682019-B1 | ELECTROCHEMICAL RECOGNITION AND QUANTIFICATION OF CYTOCHROME C OXIDASE EXPRESSION IN BACTERIA | UNIV OXFORD INNOVATION LTD (GB) | 2025-11-05 | — | — | EP | claimed |
| CN-119798990-A | Resin composition and use thereof | 苏州生益科技有限公司 | 2025-04-11 | — | — | CN | claimed |
| CN-119192573-A | Modified maleimide prepolymer, resin composition and application thereof | 苏州生益科技有限公司 | 2024-12-27 | — | — | CN | claimed |
| CN-118824098-A | Hydrogel hysteromyoma model and preparation method and application thereof | 浙江义在医疗科技有限公司 | 2024-10-22 | — | — | CN | claimed |
| CN-115873251-B | Modified maleimide prepolymer, preparation method thereof and resin composition | 苏州生益科技有限公司 | 2024-08-06 | — | — | CN | claimed |
| WO-2024140402-A1 | PREPARATION METHOD FOR MODIFIED MALEIMIDE PREPOLYMER, RESIN COMPOSITION, AND APPLICATION OF RESIN COMPOSITION | 苏州生益科技有限公司 | 2024-07-04 | — | — | WO | claimed |
| CN-116970169-B | Amine compound modified maleimide prepolymer, resin composition and application thereof | 苏州生益科技有限公司 | 2024-06-28 | — | — | CN | claimed |
| CN-118215651-A | Method for producing isocyanate compound, method for producing urethane compound, method for recovering amine compound, and isocyanate composition | 旭化成株式会社 | 2024-06-18 | — | — | CN | claimed |
| CN-117757072-A | Modified maleimide prepolymer, resin composition and application thereof | 苏州生益科技有限公司 | 2024-03-26 | — | — | CN | claimed |
| EP-1073559-A1 | TREATMENT OF SUBSTRATES TO ENHANCE THE QUALITY OF PRINTED IMAGES THEREON WITH A MIXTURE OF A POLYACID AND POLYBASE | SRI INTERNATIONAL (US) | 2001-02-07 | — | — | EP | claimed |
| EP-0592333-B1 | Polymer compositions containing organic amphiphilic electroactive charge transfer complexes and/or radical-ion salts, their manufactures and use thereof | TORAY PLASTICS EUROP SA (FR) | 2001-02-07 | — | — | EP | claimed |
| WO-1999054143-A1 | TREATMENT OF SUBSTRATES TO ENHANCE THE QUALITY OF PRINTED IMAGES THEREON WITH A MIXTURE OF A POLYACID AND POLYBASE | SRI INTERNATIONAL (US) | 1999-10-28 | — | — | WO | claimed |
| US-RE36268-E | REACTING SAMPLE WITH OXIDIZER CONTAINED IN BUFFERED SOLUTION WITHIN ELECTROLYTIC CELL, APPLYING VOLTAGE AND MEASURING RESULTING COTRELL CURRENT TO DETERMINE CONCENTRATION OF ANALYTE | BOEHRINGER MANNHEIM CORPORATION (US) | 1999-08-17 | — | — | US | claimed |
| EP-0023988-B1 | USE OF A CONDUCTIVE ORGANIC CHARGE TRANSFER MATERIAL AS ELECTRON BEAM SENSITIVE RESIST COMPOSITION, AND METHOD OF FORMING POSITIVE AND NEGATIVE RESIST IMAGES | International Business Machines Corporation (US) | 1984-02-29 | — | — | EP | claimed |
| EP-0055618-A1 | Carbonylation process employing a catalyst stabilised in soluble form | MONSANTO COMPANY (US) | 1982-07-07 | — | — | EP | claimed |
| US-4338392-A | Class of E-beam resists based on conducting organic charge transfer salts | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 1982-07-06 | — | — | US | claimed |
| US-4312936-A | Class of E-beam resists based on conducting organic charge transfer salts | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 1982-01-26 | — | — | US | claimed |
| US-4312935-A | Class of E-beam resists based on conducting organic charge transfer salts | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 1982-01-26 | — | — | US | claimed |
| EP-0023988-A2 | Use of a conductive organic charge transfer material as electron beam sensitive resist composition, and method of forming positive and negative resist images | International Business Machines Corporation (US) | 1981-02-18 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260117276-A1 | Frozen Biofluids Mitochondrial Bioenergetics Function Assessment Method for Traumatic Brain Injury and Polytrauma | MT-CO1, MT-CO2, COX5B | POLB 1124/4885CYP3A4 311/4885TSHR 3091/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.